glp-1 truth serum podcast 🎧 Ep 5: “Food Noise” is live. In this week's episode of @glp1truthserumpod Virgie talks with eating disorder specialist/meno educator, Signe Darpinian (@therapyrockspodcast). Signe answers: ✅️ What's the difference Virgie - Meet Virgie and

Kornelius stressed that the findings do not mean DPP-4 inhibitors are harmful or that GLP-1 drugs are guaranteed to protect brain health

Although the length of treatment in the +ADT group varied [mean = 52.53 days, 95% CI (44.65, 60.43)], reductions in androsterone sulfate levels were not significantly correlated with the length of ADT treatment ( p = 0.10)

This multi-criteria evaluation approach extends across prescription weight management options

These potential benefits were not maintained after treatment discontinuation

Direct head-to-head pharmacokinetic data versus SubQ NAD+ is limited

However, this absence of a documented direct interaction does not equate to a guarantee of safety or a recommendation for combined use